When Should Someone With Cancer Undergo Molecular Testing?
https://vimeo.com/1133948722 Cancer researcher Dr. Paul Oberstein explains when patients should undergo molecular testing and why early testing can be crucial. Dr. Oberstein also discusses new methods like blood-based assays that…
What Is Molecular Testing and Why Is It Necessary in Cancer Care?
https://vimeo.com/1133948743 Dr. Paul Oberstein explains how molecular testing has revolutionized cancer care, providing doctors with an essential tool to personalize treatment and, in many cases, improve outcomes for people with…
Myelofibrosis Clinical Trials | The Benefits of Patient Participation
https://vimeo.com/1036132472 How do clinical trials fit into a myelofibrosis treatment plan? Dr. Idoroenyi Amanam discusses the benefits of clinical trial participation and advice for patients who may be hesitant to…
Why Myelofibrosis Patients Should Be Engaged in Their Care Decisions
https://vimeo.com/1036132463 Dr. Idoroenyi Amanam, a myeloproliferative disorder specialist and researcher from City of Hope, shares expert perspective on the importance of patient participation in care and treatment decisions. Dr. Amanam emphasizes…
Promising Advances in Myelofibrosis Research | Optimism for Patients
https://vimeo.com/1036132446 Dr. Idoroenyi Amanam from City of Hope discusses how the availability of newer JAK inhibitor therapies is providing better options for myelofibrosis patients. Dr. Amanam also shares how researchers…
Recent Advances in Myelofibrosis Research | Disease-Modifying Therapies
https://vimeo.com/1036132429 Where is progress being made in the field of myelofibrosis? Dr. Idoroenyi Amanam discusses how disease-modifying therapies and cellular therapies are advancing patient care. Dr. Idoroenyi Amanam is a…
EVOLVE Myelofibrosis Resource Guide
Download Resource Guide Download Resource Guide See More from Evolve Myelofibrosis
Expert Perspective | A Concerted Effort to Advance Myelofibrosis Care
https://vimeo.com/1020338637 Dr. John Mascarenhas discusses the evolving landscape of myelofibrosis research, emphasizing the concerted effort among researchers, pharmaceutical companies, and advocacy organizations to advance care and treatment options for patients….
How Can You Learn More About Myelofibrosis Clinical Trials?
https://vimeo.com/1020338700 Dr. John Mascarenhas shares advice for patients looking to learn more about clinical trials starting with consulting a specialist. Dr. Mascarenhas also emphasizes key questions to ask, including a…
Expert Outlook | New Myelofibrosis Therapies Showing Promise
https://vimeo.com/1020338609 What myelofibrosis therapies in development show promise? Dr. John Mascarenhas, a myelofibrosis researcher, reviews innovative treatments that are being combined with JAK inhibitors as well as single agent therapies…
Updates in Myelofibrosis Research From an Expert
https://vimeo.com/1020338673Dr. John Mascarenhas shares updates on myelofibrosis research. Dr. Mascarenhas highlights the shift towards combination therapies, particularly the use of JAK inhibitors alongside novel agents, with the goal of improving…
How Can Specialists and Support Networks Improve Myeloproliferative Neoplasm Care?
https://vimeo.com/1011046968 What can be helpful for myeloproliferative neoplasm (MPN) symptom management and disease progression awareness? Expert Dr. Andrew Kuykendall from Moffitt Cancer Center discusses education tools and interventions, support resources, and the…